Literature DB >> 6101480

Captopril-associated agranulocytosis.

P van Brummelen, R Willemze, W D Tan, J Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6101480     DOI： 10.1016/s0140-6736(80)90629-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Captopril and systemic lupus erythematosus syndrome.

Authors:  C Sieber; E Grimm; F Follath
Journal:  BMJ       Date:  1990-09-29

2.  Inhibitors of angiotensin I converting enzyme for treating hypertension.

Authors: 
Journal:  Br Med J       Date:  1980-09-06

3.  Angiotensin converting enzyme inhibition: a new therapeutic modality.

Authors:  H Gavras; F Charocopos; H Brunner; I Gavras
Journal:  Bull N Y Acad Med       Date:  1981-05

4.  Captopril in various forms of severe therapy-resistant hypertension.

Authors:  A Studer; T Lüscher; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1981-01-15

5.  Captopril-associated lymphadenopathy.

Authors:  H Aberg; C Mörlin; G Frithz
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-14

6.  Fatal bone-marrow suppression associated with captopril.

Authors:  A el-Makri; M S Larabi; C Kechrid; C Belkahia; H Ben Ayed
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-25

Review 7.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

8.  Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation.

Authors:  Thomas A Davis; Michael R Landauer; Steven R Mog; Michal Barshishat-Kupper; Stephen R Zins; Mihret F Amare; Regina M Day
Journal:  Exp Hematol       Date:  2010-01-29       Impact factor: 3.084

Review 9.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

10.  Captopril in severe childhood hypertension--reversible anaemia with high dosage.

Authors:  H A Verhaaren; J Vande Walle; A Devloo-Blancquaert
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.